Fri-1 is an anti-cancer isoquinolinequinone that inhibits the mitochondrial bioenergetics and blocks metabolic shifts by redox disruption in breast cancer cells

Article

Abstract: Since breast cancer (BC) cells are dependent on mitochondrial bioenergetics for promoting proliferat

Palabras claves:

2-oxoglutarate dehydrogenase (OGDH), AMP-activated kinase (AMPK) signaling, CPI-613, Devimistat, Mitocans, Mitochondria, Tricarboxylic acid (TCA) cycle

Autores:

Araya-Maturana R., Córdova-Delgado M., Fuentes-Retamal S., Guzmán-Rivera D., López-Torres C., Oney O. Ramírez-Rodríguez, Palominos C., Urra F.A.

Fuentes:

scopus